Icon

Actor portrayals.

LATE STAGE IS NOT TOO LATE

To face lung cancer head on

Biomarker research continues to pave the way for personalized approaches to managing late-stage non-small cell lung cancer (NSCLC). Understanding your biomarkers may help you and your doctor make more informed decisions about your cancer care.

Late stage is considered Stage IV. In this stage, cancer has spread beyond the lung.

Stay informed and empower yourself with knowledge

Advancements in late-stage

NSCLC

Discover Quick Facts

About Biomarkers